Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Vitamin D deficiency is common in children and adolescents with chronic kidney disease.

Kalkwarf HJ, Denburg MR, Strife CF, Zemel BS, Foerster DL, Wetzsteon RJ, Leonard MB.

Kidney Int. 2012 Apr;81(7):690-7. doi: 10.1038/ki.2011.431. Epub 2011 Dec 28.

2.

Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease.

Pipili C, Dimitriadis C, Sekercioglu N, Bargman JM, Oreopoulos DD.

Int Urol Nephrol. 2012 Feb;44(1):167-71. doi: 10.1007/s11255-011-0048-1. Epub 2011 Aug 26. Review. No abstract available.

PMID:
21870088
3.

Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.

McKenna MJ, Freaney R.

Osteoporos Int. 1998;8 Suppl 2:S3-6. Review. No abstract available.

PMID:
10197175
4.

Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.

Sprague SM, Coyne D.

Clin J Am Soc Nephrol. 2010 Mar;5(3):512-8. doi: 10.2215/CJN.03850609. Epub 2010 Feb 4. Review.

5.

Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.

Andress DL, Coyne DW, Kalantar-Zadeh K, Molitch ME, Zangeneh F, Sprague SM.

Endocr Pract. 2008 Jan-Feb;14(1):18-27. Review.

PMID:
18238737
6.

Hypovitaminosis D among healthy children in the United States: a review of the current evidence.

Rovner AJ, O'Brien KO.

Arch Pediatr Adolesc Med. 2008 Jun;162(6):513-9. doi: 10.1001/archpedi.162.6.513. Review.

PMID:
18524740
7.

[Role of vitamin D in the pathogenesis of chronic kidney disease].

Cozzolino M, Brunini F, Capone V, Ricca F, Kwaidri Y, Montanari E, Cusi D.

Recenti Prog Med. 2013 Jan;104(1):33-40. doi: 10.1701/1226.13593. Review. Italian.

PMID:
23439539
8.

Comparison of mineral metabolites as risk factors for adverse clinical outcomes in CKD.

Isakova T.

Semin Nephrol. 2013 Mar;33(2):106-17. doi: 10.1016/j.semnephrol.2012.12.012. Review.

PMID:
23465498

Supplemental Content

Support Center